BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration

Reuters

12/10

BUZZ-Australia's <a href="https://laohu8.com/S/RHYN.AU">Rhythm Biosciences</a> gains on cancer test collaboration

** Rhythm Biosciences RHY.AX rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week

** Stock hits highest since December 3

** Medical diagnostics co enters collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England

** ColoSTAT test is a blood-based test used to detect colorectal cancer

** YTD, RHY down ~6%

(Reporting by Aamir Sheik Khalid in Bengaluru)

((Aamir.SheikKhalid@thomsonreuters.com))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2590037422"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2590037422\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2590037422?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-10 11:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590037422","market":"us","top_or_hot":-1,"title":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's <a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> gains on cancer test collaboration</title></head><body><p>** <a href=\"https://laohu8.com/S/RHYBF\">Rhythm Biosciences</a> <span>RHY.AX</span> rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week</p><p>** Stock hits highest since December 3</p><p>** Medical diagnostics co <span>enters</span> collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England</p><p>** ColoSTAT test is a blood-based test used to detect colorectal cancer</p><p>** YTD, RHY down ~6%</p><p> (Reporting by Aamir Sheik Khalid in Bengaluru)</p><p> ((Aamir.SheikKhalid@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-12-10 11:17</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's <a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> gains on cancer test collaboration</title></head><body><p>** <a href=\"https://laohu8.com/S/RHYBF\">Rhythm Biosciences</a> <span>RHY.AX</span> rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week</p><p>** Stock hits highest since December 3</p><p>** Medical diagnostics co <span>enters</span> collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England</p><p>** ColoSTAT test is a blood-based test used to detect colorectal cancer</p><p>** YTD, RHY down ~6%</p><p> (Reporting by Aamir Sheik Khalid in Bengaluru)</p><p> ((Aamir.SheikKhalid@thomsonreuters.com))</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7124","symbol_name":"保健護理服務","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL6N3XG05W:1","article_id":"2590037422","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590037422","pubTimestamp":1765336642,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration** Rhythm Biosciences RHY.AX rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week** Stock hits highest since December 3** Medical diagnostics co enters collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England** ColoSTAT test is a blood-based test used to detect colorectal cancer** YTD, RHY down ~6%  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7124":"保健护理服务","RHY.AU":"RHYTHM BIOSCIENCES LTD"},"translate_title":"BUZZ-澳大利亚Rhythm Biosciences在癌症测试合作中取得进展","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RHY.AU":0.9},"content_text":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration** Rhythm Biosciences RHY.AX rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week** Stock hits highest since December 3** Medical diagnostics co enters collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England** ColoSTAT test is a blood-based test used to detect colorectal cancer** YTD, RHY down ~6% (Reporting by Aamir Sheik Khalid in Bengaluru) ((Aamir.SheikKhalid@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}